These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 10582892)

  • 1. Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability.
    Westbrock-Wadman S; Sherman DR; Hickey MJ; Coulter SN; Zhu YQ; Warrener P; Nguyen LY; Shawar RM; Folger KR; Stover CK
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2975-83. PubMed ID: 10582892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoglycoside resistance in
    Thacharodi A; Lamont IL
    J Med Microbiol; 2022 Jun; 71(6):. PubMed ID: 35708991
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa.
    Islam S; Jalal S; Wretlind B
    Clin Microbiol Infect; 2004 Oct; 10(10):877-83. PubMed ID: 15373880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates.
    Sobel ML; McKay GA; Poole K
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3202-7. PubMed ID: 14506031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment.
    MacLeod DL; Nelson LE; Shawar RM; Lin BB; Lockwood LG; Dirk JE; Miller GH; Burns JL; Garber RL
    J Infect Dis; 2000 Mar; 181(3):1180-4. PubMed ID: 10720551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    Shawar RM; MacLeod DL; Garber RL; Burns JL; Stapp JR; Clausen CR; Tanaka SK
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2877-80. PubMed ID: 10582875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of the rplU-rpmA ribosomal protein operon in mexXY-expressing pan-aminoglycoside-resistant mutants of pseudomonas aeruginosa.
    Lau CH; Fraud S; Jones M; Peterson SN; Poole K
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5171-9. PubMed ID: 22825121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O
    Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    Vogne C; Aires JR; Bailly C; Hocquet D; Plésiat P
    Antimicrob Agents Chemother; 2004 May; 48(5):1676-80. PubMed ID: 15105120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress induction of the MexXY multidrug efflux genes and promotion of aminoglycoside resistance development in Pseudomonas aeruginosa.
    Fraud S; Poole K
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1068-74. PubMed ID: 21173187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in Gene
    Bolard A; Plésiat P; Jeannot K
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MexXY efflux pump overexpression and aminoglycoside resistance in cystic fibrosis isolates of Pseudomonas aeruginosa from chronic infections.
    Singh M; Yau YCW; Wang S; Waters V; Kumar A
    Can J Microbiol; 2017 Dec; 63(12):929-938. PubMed ID: 28922614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.
    Dean CR; Visalli MA; Projan SJ; Sum PE; Bradford PA
    Antimicrob Agents Chemother; 2003 Mar; 47(3):972-8. PubMed ID: 12604529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of MexXY and OpmG in aminoglycoside efflux in Pseudomonas aeruginosa.
    Chuanchuen R; Wannaprasat W; Schweizer HP
    Southeast Asian J Trop Med Public Health; 2008 Jan; 39(1):115-22. PubMed ID: 18567450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis.
    Chuanchuen R; Wannaprasat W; Ajariyakhajorn K; Schweizer HP
    Microbiol Immunol; 2008 Aug; 52(8):392-8. PubMed ID: 18667038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of amikacin resistance in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    Hurley JC; Miller GH; Smith AL
    Diagn Microbiol Infect Dis; 1995 Aug; 22(4):331-6. PubMed ID: 8582138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ; Black JA; Lister PD; Hanson ND
    J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene.
    Prickett MH; Hauser AR; McColley SA; Cullina J; Potter E; Powers C; Jain M
    Thorax; 2017 Jan; 72(1):40-47. PubMed ID: 27325751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7.
    Morita Y; Tomida J; Kawamura Y
    Microbiology (Reading); 2012 Apr; 158(Pt 4):1071-1083. PubMed ID: 22282519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the MexXY Aminoglycoside Efflux Pump and Presence of an Aminoglycoside-Modifying Enzyme in Clinical Pseudomonas aeruginosa Isolates Are Highly Correlated.
    Seupt A; Schniederjans M; Tomasch J; Häussler S
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.